Article
Evaluating the clinical utility of a molecular genetic test for polycystic kidney disease.
Molecular genetics and metabolism - 1 Jan 2000
Garcia-Gonzalez Miguel A, Jones Jeffrey G, Allen Susan K, Palatucci Christopher M, Batish Sat D, Seltzer William K, Lan Zheng, Allen Erica, Qian Feng, Lens Xose M, Pei York, Germino Gregory G, Watnick Terry J
Abstract excerpt
Autosomal dominant polycystic kidney disease (ADPKD) is estimated to affect 1/600-1/1000 individuals worldwide. The disease is characterized by age dependent renal cyst formation that results in kidney failure during adulthood. Although ultrasound imaging may be an adequate diagnostic tool in at risk individuals older than 30, this modality may not be sufficiently sensitive in younger individuals or for those...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
